Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Vanda Slams US FDA ‘Generic Bias,’ Again Seeks To Undo Hetlioz ANDA Approvals
Sep 01 2025
•
By
Dave Wallace
Is the FDA biased in favor of generics, or is it a matter of perspective?
(Shutterstock)
More from Generics
More from United States